Literature DB >> 22983826

Interleukin-22 protects rat PC12 pheochromocytoma cells from serum deprivation-induced cell death.

Yongchun Liu1, Wenyan Pan, Shengmei Yang, Xiaoying Wu, Jianfu Wu, Jun Ma, Zengqiang Yuan, Songshu Meng.   

Abstract

Interleukin-22 (IL-22), an IL-10 family cytokine, mediates the crosstalk between leukocytes and epithelial cells. Previous studies reported that IL-22 expresses in mouse brain, and the rat PC12 cells are responsive to IL-22 stimulation. However, the biological roles of IL-22 in neuronal cells remain largely unknown. We show here that IL-22 activates Stat3, p38 mitogen-activated protein kinases (MAPK), and Akt pathways and inhibits Erk/MAPK pathway in naïve PC12 cells. We further demonstrate that IL-22 protects naïve PC12 cells from serum starvation-induced cell death via the Jak1/Stat3 and Akt pathways. We also show that IL-22 has no effects on naïve PC12 cell proliferation and cannot protect naïve PC12 cells from 1-methyl-4-phenylpyridinium (MPP(+))-induced cytotoxicity. However, IL-22 exerts a dose-dependent protective effect on MPP(+)-induced neurodegeneration in nerve growth factor-differentiated PC12 cells. Overall, our data suggest that IL-22 might play a role in neurological processes. To our knowledge, this is the first report showing that IL-22 confers a neuroprotective function, which may provide a new therapeutic option for treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983826     DOI: 10.1007/s11010-012-1430-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.

Authors:  F Calon; N Lavertu; A M Lemieux; M Morissette; M Goulet; R Grondin; P J Blanchet; P J Bédard; T Di Paolo
Journal:  Synapse       Date:  2001-06-01       Impact factor: 2.562

Review 2.  Animal models of Parkinson's disease in rodents induced by toxins: an update.

Authors:  E C Hirsch; G Höglinger; E Rousselet; T Breidert; K Parain; J Feger; M Ruberg; A Prigent; C Cohen-Salmon; J M Launay
Journal:  J Neural Transm Suppl       Date:  2003

Review 3.  Interaction between cytokines, cannabinoids and the nervous system.

Authors:  Lucie Jean-Gilles; Bruno Gran; Cris S Constantinescu
Journal:  Immunobiology       Date:  2010-01-04       Impact factor: 3.144

4.  Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations.

Authors:  Marcelo Machado Ferro; Maria Ines Bellissimo; Janete Aparecida Anselmo-Franci; Miriam Elizabeth Mendes Angellucci; Newton Sabino Canteras; Claudio Da Cunha
Journal:  J Neurosci Methods       Date:  2005-06-06       Impact factor: 2.390

5.  Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus.

Authors:  Jianchun Bian; Kai Wang; Xiangang Kong; Huairan Liu; Fei Chen; Maozhi Hu; Xiaorong Zhang; Xinan Jiao; Baoxue Ge; Yantao Wu; Songshu Meng
Journal:  Arch Virol       Date:  2011-04-06       Impact factor: 2.574

Review 6.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

Review 7.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Authors:  R E Heikkila; B A Sieber; L Manzino; P K Sonsalla
Journal:  Mol Chem Neuropathol       Date:  1989-06

Review 8.  IL-22: a critical mediator in mucosal host defense.

Authors:  S J Aujla; J K Kolls
Journal:  J Mol Med (Berl)       Date:  2009-02-14       Impact factor: 4.599

9.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

10.  Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat.

Authors:  Beatriz Almolda; Manuela Costa; Maria Montoya; Berta González; Bernardo Castellano
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

View more
  5 in total

1.  Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

Authors:  Guillaume Perriard; Amandine Mathias; Lukas Enz; Mathieu Canales; Myriam Schluep; Melanie Gentner; Nicole Schaeren-Wiemers; Renaud A Du Pasquier
Journal:  J Neuroinflammation       Date:  2015-06-16       Impact factor: 8.322

2.  PACAP38 differentially effects genes and CRMP2 protein expression in ischemic core and penumbra regions of permanent middle cerebral artery occlusion model mice brain.

Authors:  Motohide Hori; Tomoya Nakamachi; Junko Shibato; Randeep Rakwal; Masachi Tsuchida; Seiji Shioda; Satoshi Numazawa
Journal:  Int J Mol Sci       Date:  2014-09-23       Impact factor: 5.923

Review 3.  Interleukin 22 and its association with neurodegenerative disease activity.

Authors:  Wenjian Chen; Jianpeng Wang; Huaizhi Yang; Yuankai Sun; Bangjie Chen; Yuchen Liu; Yanxun Han; Ming Shan; Junfeng Zhan
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

4.  Paroxetine combined with fluorouracil plays a therapeutic role in mouse models of colorectal cancer with depression through inhibiting IL-22 expression to regulate the MAPK signaling pathway.

Authors:  Huijie Zhang; Meixv Chen; Ying Liu; Xiaomei Dong; Chan Zhang; Han Jiang; Xue Chen
Journal:  Exp Ther Med       Date:  2020-10-22       Impact factor: 2.447

5.  Interleukin-22 Plays a Protective Role by Regulating the JAK2-STAT3 Pathway to Improve Inflammation, Oxidative Stress, and Neuronal Apoptosis following Cerebral Ischemia-Reperfusion Injury.

Authors:  Yongfei Dong; Chengyun Hu; Chunxia Huang; Jie Gao; Wanxiang Niu; Di Wang; Yang Wang; Chaoshi Niu
Journal:  Mediators Inflamm       Date:  2021-03-12       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.